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The investigation of protein quaternary structure, protein-cofactor, and protein–ligand inter-
actions by mass spectrometry is often limited by the fragility of such interactions under
experimental conditions. To develop more gentle conditions of perhaps general use, we used
as a model for study the oxygenase domain of murine inducible nitric oxide synthase (iNOS),
which is homodimeric, binds heme and tetrahydrobiopterin H4B cofactors, and the substrate
L-arginine. The energetics of the collisions in q2 and in the lens region of the mass spectrometer
were manipulated for varying the degree of solvation around the non-covalently bound ions.
Furthermore, the number of low-energy collisions in the collision cell of the instrument was
varied, focusing and dampening the ion beam. Under gentle source collision conditions, and
using multiple low-energy collisions in the collision cell of the mass spectrometer, dimers of
the iNOS oxygenase domain containing heme, H4B, and arginine were observed intact after
electrospraying at pH values near neutrality; a mutant of this protein (Trp188 3 Phe) was
monomeric and did not bind cofactors. The pH dependence of the iNOS oxygenase domain
under acidic conditions was also studied; while heme remained bound to the protein between
pH 2.5 and 4.0, the dimeric structure was disrupted. Our findings confirm that non-covalently
bound macromolecular complexes are retained and observable using electrospray mass
spectrometry under the appropriate experimental conditions. (J Am Soc Mass Spectrom 2004,
15, 629–638) © 2004 American Society for Mass SpectrometryThe enzyme nitric oxide synthase (NOS) is anappropriate focus for studying non-covalent in-teractions as few proteins rival it for the richness
in variety in which it partakes. These include the
binding of four cofactors (two flavins, a heme, and a
pterin), three substrates (L-arginine, NADPH, and oxy-
gen), and at least two protein–protein interactions (be-
tween subunits of this homodimeric enzyme and inter-
actions with the small calcium-sensing protein
calmodulin, which regulates enzyme activity). In spite
of the many functional differences, the NOS isotypes
produce NO by the same mechanism:
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This similarity in mechanism is a consequence of
structural homology within the NOS isotypes. All
isotypes have a common domain architecture consist-
ing of an oxygenase domain that binds heme and
tetrahydrobiopterin (H4B) linked by a short calmod-
ulin binding site to a carboxy-terminal reductase
domain which, in turn, binds flavin cofactors [1].
Electrons are transferred from NADPH via the reduc-
tase domain to the oxygenase domain, which is the
site of oxygen binding and NO production. Further-
more, NOS is active only as a dimer; dimerization
requires the presence of the heme cofactor and is
stabilized further by binding of H4B and arginine [2].
NOS dimerization occurs primarily through interac-r Inc. Received October 29, 2003
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subunits [3].
The organization of NOS into distinct structural
domains lends itself to their study as independent
species, obtained either by limited proteolysis of the
complete protein or by recombinant expression. For
example, the independently expressed oxygenase do-
main of NOS retains the capacity to bind cofactors,
substrate, and to dimerize, and thus reflects the struc-
tural and functional properties of this domain in the
intact protein [4]. Establishing a gas-phase representa-
tion of the equilibrium between oxygenase monomers
and dimers will allow a standard to be set to which
future modifications of the protein (i.e., point muta-
tions) may be compared. As dimerization directly cor-
relates to the protein’s ability to be active, studying
factors that affect this equilibrium may allow the eluci-
dation of key stabilizing residues or inhibitory sub-
stances.
Mutational studies commonly allow insight into the
intra-physiological processes and key residues within a
protein. Recently, it has been reported that a mutant
form of the inducible NOS (iNOS) oxygenase domain
has been created, and that this mutant lacks the ability
to bind the cofactor heme [5]. In this mutant, the 188th
amino acid residue, tryptophan, is replaced by phenyl-
alanine. It is thought that this tryptophan residue in the
wild type plays a major role in stabilization of the heme
in the heme-binding pocket; it has been shown that,
through a mutation to a phenylalanine residue, the
heme binding becomes severely destabilized despite the
protein remaining folded [5]. The present study also
examines this mutant (known as the W188F) in order to
observe its gas-phase behavior and any non-covalent
interactions that may be present.
With the advent of soft ionization techniques, such as
electrospray ionization (ESI) and matrix-assisted laser
desorption ionization (MALDI), large biomolecules are
now accessible to investigation using mass spectro-
metry (MS). It has been stated that nanospray, a low-
flow subclass of ESI, is even softer [6, 7] and has a
greater tolerance for non-volatile salts [8] than conven-
tional electrospray, thereby making it even more suit-
able for the study of non-covalent interactions. There
are now a number of reports that detail the observation
of non-covalent interactions using mass spectrometry,
and this topic has been recently reviewed by several
groups [9–13]. Most of these studies dealt with rather
strong, electrostatic interactions that are arguably en-
hanced in the absence of solvent, [14] e.g., protein/
DNA complexes [15], DNA/ligand complexes [16],
heme/protein and other interactions [17–19]. Extensive
time and effort have also gone into studying protein/
protein interactions through mass spectrometry [14,
20–26]. A few groups have reported the ability to
observe hydrophobic non-covalent interactions by mass
spectrometry including leucine zipper peptides [27] as
well as acyl CoA derivatives to acyl CoA binding
protein [28]. Both studies reported a very low relativeabundance of non-covalently bound species (10–20%
or less), which was somewhat expected as hydrophobic
interaction is likely to diminish in the absence of
solvent. The degree of hydrophobicity of a particular
non-covalent interaction was rarely discussed, perhaps
because it is not fully known, or due to the fact that,
upon transfer to the gas phase, hydrophobic stabiliza-
tion effects diminish, while electrostatic effects are
generally enhanced. It has been reported that, in the
endothelial NOS isotype, 55% of the dimer interface
consists of hydrophobic residues, thereby showing that
dimer stability relies heavily on entropic effects of the
surrounding aqueous solvent [29]. Due to the high
degree of homology between the NOS isoforms, it may
be inferred that hydrophobic effects likely play a sig-
nificant role in the dimerization of both the inducible
and neuronal isoforms as well. However, in the gas
phase, one would expect the electrostatic interactions
along the dimer interface to be the major contributor to
dimer stability. Deciphering the exact nature of the
forces that contribute to gas-phase protein/protein in-
teractions, including that in the NOS dimer, is currently
intractable.
Mass spectrometric sampling from an electrospray
source results in cooling of the ions due to gas expan-
sion and subsequent heating via downstream collisions
with sampled gas molecules in the presence of an
electric field. Collisional heating is generally required in
order to adequately desolvate the ions, and can be
“harsh” when the pressure drop is large, allowing the
ions to acquire significant energy from the electrostatic
field in between collisions (because of the long mean
free path). Alternatively, it can be “gentle” when, under
the same electrostatic field, the pressure differential is
relatively small [30]. It has been shown that “collisional
cooling”, i.e., a large number of gentle collisions, helps
preserving weak interactions, and allows for sufficient
resolution of non-covalently bound macromolecules
without significant fragmentation [30–33]. Several re-
cent studies have described deliberate increases of the
pressure in the sampling hexapole (equivalent to q0 in
our instrumental setup) that was upstream to the first
mass analyzer [30, 31, 33]. The many low-energy colli-
sions were believed to be sufficiently energetic to shed
the attached solvent molecules from the macromolecu-
lar complex; however, they were not energetic enough
to cause fragmentation of the complex itself [30, 31]. In
addition, these low-energy collisions served to dampen
ion motion in the radial direction of the multipole and
concentrate the ions onto the central axis, thereby
improving ion transmission and sensitivity [32, 34–36].
In our present study, we employ a collisional cooling
strategy that utilizes an additional region for implemen-
tation. The q0 continues to allow for a degree of
collisional cooling due to the conventional pressure
gradient in that region; however, here, the collision cell
(or second quadrupole, q2) is employed as an addi-
tional region where multiple, low-energy collisions can
take place. It has previously been shown that the
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through collisional cooling, and focusing, over a dis-
tance of about 15 cm, is 10 mTorr [37]. Therefore, we
endeavour here to optimize the relative abundance of
NOS dimer ions by performing experiments in this
pressure range as well as with gas pressures that exceed
this value.
We also report MS/MS results of the iNOS oxygen-
ase domain. Several groups have studied the effects of
conducting MS/MS on full-length proteins, specifically
citing the trends associated with ferri- and ferro-heme
loss from various heme proteins [38–41]. The presence
of some cofactors may be determined within a protein
through their loss from the complex. If the cofactor is
charged, e.g., it is a ferri-heme, its loss will be evidenced
by the presence of the cofactor ion and a lower-charge
as well as lower-mass protein ion [38].
Experimental
Recombinant oxygenase domain was expressed and
purified as described previously [42]. The protein was
purified in the presence of H4B (100 M) and L-arginine
(5 mM). The calculated isoelectric point (pI) of the NOS
oxygenase domain is 6.3. Due to the aggregation ob-
served at pH  6.3, two buffer exchange techniques
were employed to produce samples suitable for electro-
spraying. About 100 L of purified iNOS oxygenase
domain was brought to the desired pH by either
dialysis against two 500 mL volumes of 0.001–0.34%
formic acid for a total of three hours in the case of acidic
samples, or through size exclusion chromatography
(SEC) (P10 Sephadex, Qiagen, Mississauga, Canada)
into 10 mM ammonium acetate adjusted to pH 7.0 in the
case of neutral and basic samples. For these solutions,
no aggregation state was observed as the pH was never
near or passed through 6.3; SEC provided the quickest
method for exchanging the buffer. Speedy sample prep-
aration reduced the risk of disrupting the non-covalent
interactions due to non-physiological salt concentra-
tions. For acidic solutions, SEC could not be used, as the
protein aggregated and stuck to the column; dialysis
was used instead, allowing the protein to aggregate and
then dissolve back into the solution once the pH inside
the dialysis chamber fell below 6.3. In some experi-
ments, the ammonium acetate was replaced by 10 mM
ammonium bicarbonate or 10 mM triethylammonium
bicarbonate for testing the effect of changing the buffer;
in others, ammonium hydroxide or triethylamine was
added to solutions to raise the pH to between 7 and 10
for evaluating the effect of changing the pH. The
protein samples were diluted to 5 M before analysis.
Mutational studies using the W188F variant were
also conducted in 10 mM ammonium acetate. The
mutant was created as described previously [5], and
was purified in a procedure identical to the wild type
protein. SEC was also used for the W188F species;
however, it was noted that below pH 7.5, the protein
would aggregate. Therefore, the minimum pH in whichthe mutant was placed was 7.5. Solutions of 5 M
concanavalin A and human hemoglobin were also
prepared in 10 mM ammonium acetate, pH 7.5. Unless
otherwise indicated, all reagents were obtained from
Sigma-Aldrich Chemical Co (St. Louis, MO).
The mass spectrometer used for all initial experi-
ments was an MDS Sciex Centaur (Concord, ON), a
prototype version of MDS Sciex’ commercially available
QSTAR hybrid quadrupole time-of-flight (QqTOF) tan-
dem mass spectrometer. Nanospray (MDS Proteomics,
Odense, Denmark) was used for sample introduction
using custom-made “short” gold/palladium alloy-
coated silica capillaries. Nitrogen was used both as the
curtain and the collision gas. The Centaur was modified
in-house for higher-pressure operations in q2. By in-
creasing the collision gas inlet pressure, the maximum
collision-gas pressure was approximately doubled. An
upstream pressure regulator was installed for precise
pressure control. The working pressure in q2 was
regulated by a series of four unique flow-limiting
orifices that are controlled in a binary fashion by four
solenoid valves. The actual pressure in the q2 was not
measurable in the current setup. However, previous
measurements of the original instrument configuration
at Sciex allow us to estimate that at the maximum
setting, the pressure in the q2 is approximately 12
mTorr. Lower pressures are accessible by opening or
closing the appropriate binary configuration of the four
solenoid valves to create 12 levels of differing q2
pressure in a range of approximately 1 to 12 mTorr. To
maintain proper operating pressure in the analyzer
regions of the mass spectrometer, a fourth turbomolecu-
lar pump was added to evacuate the analyzer region,
i.e., the vicinity of Q1 and q2. The optimal source
voltages varied with each experiment, allowing for
various degrees of desolvation and resolution. Nanos-
pray voltages ranged from 800–1200 V. Orifice and
curtain plate voltages ranged from 11–50 V for a low
degree of desolvation, and 100–140 V for a high degree
of desolvation. Ring voltages varied proportionately to
the orifice voltages at 120–175 V for the former, and
200–275 V for the latter condition. The skimmer voltage
was typically held at 26 V. Individual voltages were
optimized for each experiment in order to maximize the
relative abundance of non-covalently bound species
observed and to attain the desired level of desolvation.
Most experiments were repeated on two QSTAR XL
prototype QqTOF mass spectrometers at MDS Sciex
(designated as XL 1 and XL 2 for differentiation in this
manuscript). The two XL instruments are functionally
identical to each other with respect to their ion sources,
ion optics hardware, and operating pressures (albeit
different in design details). They differ from the Cen-
taur as follows: First, the XL instruments have LINAC II
collision cells, whereas the Centaur does not. LINAC II
collision cells provide an axial potential gradient along
the collision cell [43], whereas the older model collision
cell in the Centaur does not. Second, the XL instruments
have lower frequency Q1 rods, meaning they are able to
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(8000 Th); the Centaur is restricted to a maximum
limit of 3000 Th. Third, as described above, the Centaur
was modified to allow greater pressures in its collision
cell than the other two instruments without causing the
instrument to lose its operating pressure. After modifi-
cation, the pressure in the q2 of the Centaur could reach
24 mTorr, approximately 1.5 times as great as the
maximum pressure allowed in the XL instruments.
Finally, although both the XL and Centaur instruments
were run on a Macintosh platform, their versions of
TOFMA (spectral attaining and displaying software)
were different. The significance in this is that the
relative ion abundances impinging upon the four de-
tector plates of the MCP detector was easily observable
for the XL instruments, but not so for the Centaur. It
will be shown that, for the same type of iNOS solutions,
the relative distribution of monomeric and dimeric ions
under various pressure conditions in q2 is dependent
on the instrument type (i.e., XL versus Centaur).
Results and Discussion
General Observations for Neutral iNOS Solutions
Observation of the dimeric iNOS oxygenase domain
required careful optimization of lens voltages and gas
flows. However, once these conditions were found, they
were generally applicable for both the XL and Centaur
instruments, with some minor adjustments needed be-
tween experiments due to spraying variation. As a
control, both concanavalin A and hemoglobin were
sprayed in order to confirm the optimized instrument
parameters and trends noted herein; in both cases a
majority of tetrameric species was observed (data not
shown) in accordance with previous observations [21,
22]. It was quickly discovered that increasing the q2
pressure in the Centaur beyond its original limit did not
offer any advantage. The ion intensity decreased at a
pressure 12 mTorr, presumably due to scattering [30].
In general, the trends are similar in all three instru-
ments, although there are exceptions. In all three instru-
ments, introduction of the collision gas into q2 (within
the 0–12 mTorr limit) increases the abundances of
protein ions. Figure 1 shows the relationships between
absolute dimer abundance and q2 pressure for the three
instruments. It should be noted that the intended com-
parison is the change in abundance within a given
instrument with q2 pressure, and not the change in
absolute abundance of a given q2 setting among the
three instruments; the experiments were carried out
with different nanospray capillaries and hence differing
spray conditions. Introducing the collision gas increases
the absolute abundance of dimer ions. This increase is
approximately linear for the XL 1 and XL 2 instruments
throughout the pressure range from 0 to 16 mTorr, but
levels off at approximately 8–10 mTorr for the Centaur
and then reverses itself (i.e., the abundance decreases
beyond this range). The effect of q2 pressure on therelative abundance between the dimer and the mono-
mer ions, however, is quite different between the Cen-
taur and the XL instruments (Figure 2). On the Centaur,
a substantial increase in the relative abundance of
dimer ions is observed as the q2 pressure is increased
up to approximately 10 mTorr (above this pressure it
decreases), whereas on the XL the relative abundance is
Figure 1. Plot of the ratio of absolute dimer abundance versus
the pressure within the q2 for the Centaur, XL 1, and XL 2
instruments. The line with the filled diamonds represents the
trend for the Centaur, the line with the filled circles represents the
trend for the XL 1, and the line with the filled squares represents
the trend for the XL 2. The asterisks indicates that the abundance
for the XL 1 instrument has been multiplied by (1 102) to allow
easier comparison between the instruments. In each experiment,
the source collision conditions were gentle, (orifice potential was
set to 30 V), and the collision energy was low (Elab  7.5 V).
LINAC voltages in the XL 1 and 2 were both set to 50 V.
Figure 2. Plot of the ratio of relative dimer to monomer abun-
dance versus the pressure within the q2 for the Centaur and XL 1
instrument (the XL 2 instrument showed similar results to the XL
1). The line with the filled diamonds represents the trend for the
Centaur, and the line with the open triangles represents the trend
for the XL 1. In each experiment, the source collision conditions
were gentle, (orifice potential was set to 30 V), and the collision
energy was low (Elab  7.5 V). LINAC voltages in the XL 1 and 2
were both set to 50 V.
633J Am Soc Mass Spectrom 2004, 15, 629–638 COLLISIONAL COOLING WITHIN THE OXYGENASE DOMAINessentially independent of q2 pressure. The increase in
absolute abundance with increasing q2 pressure is
likely an effect of collisional focusing [30, 32] and the
decrease is in accordance with the expectation of in-
creasing scattering due to increasing numbers of colli-
sion [30]. The different behaviors between the Centaur
and the XL instruments are puzzling but are likely a
consequence of different q2 designs (vide infra).
Figure 3 shows typical iNOS mass spectra obtained
from a 10 M solution at a pH of 7.0 and at a q2
pressure of 10 mTorr on (Figure 3a) the Centaur and
(Figure 3b) the XL 1. The maximum charge states
observed in the dimer and monomer ion envelopes are
slightly different on the two instruments. These differ-
ences are within the variations observed within a given
instrument, and are attributable to different optimal
instrumental conditions (different nanospray voltages,
curtain gas pressures, etc.). Changing the nature of the
buffer salt produced little change to the spectra, except
that, with everything else being equal, there was a shift
towards lower charge states, when triethylammonium
bicarbonate was used. This shift is in line with the
higher proton affinity of triethylammonia than that of
ammonia; the former is expected to be much more
efficient than the latter in competing with iNOS for the
protons [44]. Furthermore, raising the solution pH from
7 through 10 appeared also to have little effect on the
spectra. Figure 3b also shows existence of dimer ions
that have lost one or both heme groups. This is most
Figure 3. Typical iNOS oxygenase domain ma
7.0 (10 mM ammonium acetate) and at a q2 pre
Source collision conditions were harsh (orifice po
are labeled, followed by their charge state (i.e., D
no heme loss (filled circle), with one heme mole
lost (asterisk).likely a gas-phase phenomenon as heme is knocked out
via collisional activation and dimer disruption does not
occur on the time scale of the MS experiment. Note that
in Panel a, a greater degree of solvation is observed and
no heme-free peaks are seen. This concept was also
examined by conducting experiments varying the
source collision conditions. Under harsher condi-
tions, heme-free dimers became more apparent; the
gas-phase nature of these reactions was confirmed by
collision-induced dissociation (CID) experiments
(vide infra).
Acidic iNOS Solutions
Acidic solutions of the iNOS oxygenase domain were
also examined. Lowering the pH from 7.0 results in
aggregation of the protein at pH 5.5–6.5. Further
lowering of the pH results in protein re-dissolution. The
nanoelectrospray mass spectra of iNOS oxygenase do-
main solutions at pH 2.5–4.0 show the presence of only
monomers. Under mild source conditions (Figure 4a
showing pH  3.5), the monomers are all heme-bound;
under harsher source conditions (Figure 4b showing pH
 3.5), both heme-free and heme-bound monomers are
observed. Decreasing the pH shifts the centroid of the
charge state distribution towards increasing charge; in
addition, it increases the relative ratio of heme-free to
heme-bound monomers. These observations are in
ectra obtained from a 5 M solution at a pH of
of 10 mTorr on (a) the Centaur and (b) XL 1.
al (OR) of 140 V). Monomers (M) and dimers (D)
 [2M  21H]21). In (b), species are seen with
ost (open circle), and with two heme moleculesss sp
ssure
tenti
21
cule l
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lower pH, more protons are available for attachment
(therefore, more highly charged protein ions are
formed) and more extended is the iNOS conformation
(therefore, the heme is more loosely bound).
W188F Mutant
The W188F mutant solutions were electrosprayed un-
der conditions that were optimal for observation of the
dimeric iNOS oxygenase domain. Figure 5 shows a
typical mass spectrum. It is evident that no dimer ions
are visible. The monomers are heme-free. These obser-
vations are in accordance with the expected absence of
dimeric mutant in solution, and poor heme binding of
the mutant monomer.
More Detailed Analysis of the iNOS Oxygenase
Domain
The molecular weight of one monomeric iNOS oxygen-
ase domain polypeptide chain is 50548.6 Da. The loss of
the N-terminal methionine residue (a common occur-
rence) results in a total mass of 50417.4 Da, adding
heme (MW 616.2) gives a mass of 51033.6 Da. The
dimeric form of this protein is, therefore, expected to
have a mass of 102067.2 Da. However, H B has been
Figure 4. Mass spectra of 10 M iNOS oxygen
high (OR  140 V) source collision conditions
represents a difference charge state of the monom
M34  [M  34H]34)] with zero (open circle),
bound. Heme proteins have been shown previou
molecules per monomer) in the gas phase.4shown to provide stability to the dimeric structure; one
or two molecules of H4B (MW 241.1 Da) would result in
omain at pH 3.5 at (a) low (OR  50 V) and (b)
ined on the Centaur. Each peak in the spectra
protein [labeled M, followed by charge state (i.e.,
(filled circle), or two (asterisk) heme molecules
5] to behave in this manner (i.e., bind two heme
Figure 5. Mass spectrum of 5 M iNOS oxygenase domain
mutant protein, W188F, in 10 mM ammonium acetate solution, pH
7.5 obtained on the XL 1. The orifice voltage was set to 11 V, and
the pressure in the q2 was set to 11 mTorr. Peaks are labeled as M
(monomeric) followed by the charge state (i.e., M15  [M 
15H]15). The spectrum shows only a monomeric species that is
devoid of the heme cofactor, thus confirming that this mutant
species does not dimerize, nor bind heme.ase d
obta
eric
one
sly [4
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tively. Furthermore, the protein isolation protocol in-
volved purification in the presence of the substrate
arginine (MW 174.1 Da); each subunit in a dimer may
bind this molecule giving total masses of 102723.5 Da
for one, and 102897.6 Da for two arginine molecules
binding to the protein.
Deconvolution of spectra obtained at low orifice
potentials (30 V or less) reveals monomers with an
average mass of 51245  3 Da, and dimers with an
average mass of 103174  6 Da. These masses might
indicate that the monomer contains heme and possibly
a molecule of arginine as well; however, further exper-
iments revealed that arginine is in fact not bound, and
that the additional mass is due to solvent and salt
molecules (vide infra). The mass of the dimer in these
conditions is sufficiently large for the postulation that
two molecules of H4B as well as two molecules of
arginine are bound to the dimer, in addition to two
heme molecules and some solvent molecules. As orifice
potentials were raised, monomers shed adducted sol-
vent molecules to reveal an average mass of 51057  2
Da, (the difference between this value and 51033.6 Da
Figure 6. CID mass spectra of the (a) [2M  21
from a 5 M iNOS oxygenase domain in 10 mM
XL 1. The dimer ion peak was subjected to soft so
energy of Ecm  0.338 eV (corresponding to a p
monomer ion peak was subjected to harsh sour
energy of Ecm  0.675 eV (corresponding to a po
mass peaks are labeled on the inset spectra; H4
protonated tetrahydrobiopterin with a neutral m
sodiated tetrahydrobiopterin with a neutral ma
clearly seen through the appearance of the hem
parent, which contains heme (labeled with a fille
followed by their charge state (i.e., D21  [2Mindicates there is residual adduction of water or so-
dium); a small amount of heme loss was also observed.
Dimer ions also lost mass as the orifice potential was
increased, revealing an average mass of 102644  10 Da
at a moderate potential (75 V), and 102143  4 Da at a
high potential (140 V). The former of these two mass
values lies 96 Da above the expected mass of a dimer
containing two molecules of heme and H4B; the latter
above the expected mass of a dimer containing only two
molecules of heme plus the mass of some unknown
adduct or solvent molecule(s) equalling 77 Da. To
characterize the iNOS components that were lost with
increasing potential, CID experiments were conducted
on both monomers and dimers on the XL 2 instrument.
Figure 6 shows MS/MS spectra of (Figure 6a) a
dimer ion, and (Figure 6b) a monomer ion. The dimer
ion subjected to MS/MS (Figure 6a) is the [2M 
21H]21 ion at m/z 4975, corresponding to a dimer mass
of 104454 Da, significantly larger than the mass of a
dimer containing two heme, two H4B, and two arginine
groups. The spectrum reveals very little heme loss, but
considerable losses of H4B and arginine (see the inset).
Furthermore, four ions of lower charge states (17 to
dimer ion, and (b) [M  15H]15 monomer ion
onium acetate solution, pH 7.5 obtained on the
collision conditions (OR 30 V), and a collision
tial difference between q0 and q2 of 60 V). The
llision conditions (OR  140 V), and a collision
al difference between q0 and q2 of 120 V). Low
tetrahydrobiopterin,, heme  ferri-heme, a 
oss of 76 Da, b  protonated arginine, and c 
ss of 76 Da. The loss of neutral heme in (b) is
ee peak (labeled with an open circle) from the
cle). Monomers (M) and dimers (D) are labeled,
H]21).H]21
amm
urce
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ce co
tenti
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that they are dimeric iNOS oxygenase domain that are
heme-bound but have lost their adducted H4B and
arginine molecules as ions that are seen in the inset. In
addition, losses of neutral H4B, arginine, and heme
from the precursor ion ([2M  21H]21) have also been
observed; these are revealed by shoulders and partially
resolved details in expanded windows of the dimeric
ions, (not shown). It is interesting that there is a distinct
lack of monomeric species generated from these exper-
iments. As alluded to before, this could possibly be due
to the kinetics of the dimer separation requiring more
time than the analysis time of the experiment.
Under energetic collision conditions, the loss of
heme from the monomer was observed (Figure 6b); H4B
or arginine ions were not observed at any collision
energy, in accordance with the expectation that they are
not bound by the monomer. The loss of neutral ferro-
heme from the precursor ion (both monomers and
dimers) was also observed (not shown).
As a control, fragmentation studies were conducted
on dimer ions with masses lower than 102,308.3 Da
(generated by increasing the orifice potential to 140 V).
The [2M  19H]19 ion at m/z 5380 (corresponding to a
mass of 102,220 Da) was fragmented (data not shown).
This ion is not expected to contain H4B or arginine; its
fragmentation was considerably simpler, showing pre-
dominantly the loss of ferri-heme.
The dimeric form of iNOS oxygenase domain has
been shown through crystallography studies to contain
a lone zinc ion coordinated by four cysteine residues
along the dimer interface; this structure has been sug-
gested to contribute to the stability of the complex [46].
There was no indication, however, of the presence of
zinc in any of the experiments; no adduct of zinc was
ever observed, nor was zinc lost as an ion in any CID
experiments. Inductively-coupled plasma mass spectro-
metric analyses reveal an abundant concentration of
approximately 8 mM of zinc in the samples and buffer
solutions, consistent with background levels from con-
tamination of the buffers and solvents. The apparent
lack of zinc in the iNOS could indicate that it is either
weakly bound within the complex itself, therefore being
easily lost in the transition to the gas phase, or it may
not bind at all in the solution conditions that are used.
Experiments were also conducted at different colli-
sion energies, for evaluating the relative barrier to
fragmentation. The loss of heme requires higher colli-
sion energy relative to H4B and arginine. Lower energy
collisions (Ecm  0.338 eV for the first collision, corre-
sponding to a potential difference between q0 and q2 of
60 V) produced more abundant H4B and arginine ions
than the heme ion. These observations were confirmed
through deconvolution of the protein ions of lower
charge; no heme loss was evident at low collision
energies. As collision energy was raised, the relative
abundance of the heme ion increased dramatically,
accompanied by obvious losses of both the ferri- and
ferro-heme from the protein ions. At higher energies(Ecm 0.675–0.844 eV for the first collision, correspond-
ing to a potential difference between q0 and q2 of
120–150 V), the abundance of H4B ions did not increase
nearly as much as the heme ion; this could be due to
fragmentation of the former to smaller products, or that
these higher energy conditions favoured other fragmen-
tation channels.
As a final confirmation that the iNOS oxygenase
domain mutant W188F did not bind cofactors, CID
experiments were performed on the [M  16H]16 ion
at m/z 3312. This ion has a mass of 52976 Da, indicating
that it is excessively solvated and/or has cofactors
bound to it. The absence of charge loss under collision
conditions of 100 eV was taken as proof that no cofac-
tors were bound (data not shown).
Additional Discussion regarding Instrumental
Discrimination
The Centaur uses a conventional quadrupole rod set in
q2, whereas the XL employs a LINAC II rod set that
imposes an axial electric field [43]. It is expected that, all
other conditions being equal, ions injected into the q2 of
the Centaur will spend a longer time within the quad-
rupole than those ions injected into the q2 of the XL
instruments. To investigate the effect of this residence
time, the axial electric field gradient in the XL 1 instru-
ment was varied. Figure 7 shows that as the density of
the collision gas in q2 increased, the effect of this
potential gradient was more dramatic. At lower gradi-
ents (0–0.005 Vcm1, corresponding to LINAC volt-
ages of 0 to 10 V), monomer ions were relatively less
intense than the dimer ions; as gradient increased, the
relative abundance of the monomer ions increased
approximately logarithmically. It was also noted that
the near logarithmic curve became less steep as the q2
Figure 7. Plot of the ratio of relative monomer to dimer abun-
dance versus the voltage applied to the LINAC II axial gradient
within the q2 for the XL 1 instrument (the XL 2 instrument showed
similar results to the XL 1). The line with the filled diamonds
represents a q2 pressure of 6.3 mTorr, and the line with the filled
squares represents a q2 pressure of 16.7 mTorr.
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electric field in its q2, its behavior as seen in Figure 2
mirrors that of the XL instruments operated under
non-optimal electric field gradient. The XL instruments,
however, maintain an optimal gradient near the limit of
the logarithmic slope (i.e., at an operating LINAC
voltage of 50 V in all experiments), and hence the
relative abundances of the dimers and monomers did
not change appreciably as the q2 gas density was raised.
The fact that the ratio of monomer to dimer ion levels
off at high LINAC voltages is in accordance with the
expectation that the monomer ions are not created by
the presence of the LINAC voltage (otherwise the trend
would continue to greater relative monomer abundance
as the voltage increased), but are released from the
collision cell by this axial potential gradient. These
results suggest that longer residence times within the q2
discriminates against the lighter monomer ions.
In addition, dimer discrimination was observed in
the TOF section of the XL instrument at q2 pressures
lower than 6 mTorr. Presumably, this also occurs in
the Centaur; however, the older software used in the
Centaur to monitor the internal processes of the instru-
ment makes it difficult to confirm this. At pressures
lower than 6 mTorr, dimers were observed to be
biased towards the fourth quadrant (furthest from q2)
in the MCP detector of the XL, indicating that these ions
entered into the TOF region of the instrument with
residual kinetic energy in the axial direction of the
quadrupoles; this potential problem has been noted
before [33, 34]. This excess energy caused the dimer ion
beam to not be centered on the detector, and a percent-
age of these ions might have missed the detector
altogether after time-of-flight. This phenomenon was
not observed with the monomers, which were well
centered. As suggested by Chernushevich and Thom-
son [36] in their studies of large non-covalent clusters,
this indicates that at lower q2 pressures (less than 6
mTorr in our case), the dimer ions do not undergo
enough collisions in q2 to fully dampen their kinetic
energy in the axial direction. Monomers, however,
because of their larger cross-section per unit mass, have
their axial kinetic energy more efficiently dampened,
and enter the TOF section at the optimum energy for
detection.
Our results support the notion that some of the
solution-phase chemistry associated with non-co-
valently bound proteins is retained in the gas phase. In
every case, solutions containing proteins known to
non-covalently associate with each other showed this
behavior in our gas-phase experiments. Furthermore,
those species that do not associate with each other in
solution retained this behavior in the gas phase, as seen
with the W188F iNOS oxygenase domain mutant. Ad-
ditionally, CID experiments revealed that cleaving of
the heme required a higher energy than cleaving of
tetrahydrobiopterin or arginine. In solution, binding of
the heme occurs first to monomeric units, and then the
two other cofactors bind during or after the process ofdimerization. It is interesting that this order of reaction
correlates with the order of decreasing CID energy.
Conclusion
The iNOS oxygenase domain dimer was observed intact
and partially solvated using three hybrid quadrupole
time-of-flight mass spectrometers. In general, observa-
tion of abundant dimer ions requires relatively high
pressure in q2. Furthermore, binding of heme, H4B, and
arginine was demonstrated via CID of the dimer ion.
iNOS oxygenase domain was also run in acidic
solutions. The results showed that although the heme is
not lost from the protein between pH 2.5 and 4.0, the
dimeric structure is disrupted. Finally, solutions of the
iNOS oxygenase domain mutant W188F were also run
under optimal conditions for the dimer ions, confirming
that this species neither dimerizes, nor binds heme.
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